AI Revolutionizes Breast Cancer Screening in Qatar

Seoul, South Korea - Lunit (328130 KQ) announced the implementation of its AI-powered breast cancer detection solution in Qatar's national breast cancer screening program, marking the first such nationwide adoption in the Middle East.

Qatar's Primary Health Care Corporation (PHCC) will integrate Lunit INSIGHT MMG into its "Screen for Life" program starting in June 2024. 

The partnership is set for an initial period of five years.

The AI solution aims to enhance early detection of breast cancer in Qatar's triennial screening program. 

Two radiologists now read each mammogram while referring to Lunit INSIGHT MMG's results.

The implementation follows a successful retrospective validation phase that began in March 2023.

Lunit has recently deployed AI solutions in national cancer screening initiatives in Australia, Sweden, Saudi Arabia, and Iceland.

The "Screen for Life" program offers free breast and bowel cancer screening to eligible residents in Qatar.